Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WuXi Biologics Receives EMA GMP Certificates for Trogarzo | Contract Pharma

What are you searching for?

Sign in
Breaking News

WuXi Biologics Receives EMA GMP Certificates for Trogarzo

To provide cGMP Drug Substance and Drug Product manufacturing at Wuxi city and cGMP cell banking facilities in Shanghai

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi Biologics has received EMA GMP certificates for the production of Trogarzo at its cGMP Drug Substance and Drug Product manufacturing facilities in Wuxi city and its cGMP cell banking facilities in Shanghai. Trogarzo, an HIV treatment, is developed by TaiMed Biologics and marketed in the U.S. and EU by Theratechnologies.
 
“This marks yet another great milestone that WuXi Biologics has achieved and lays a solid foundation for us to significantly expand our manufacturing capacity and capabilities,” said Dr. Chris Chen, chief executive officer of WuXi Biologics. “With the recognition from both the U.S. FDA and EMA, WuXi Biologics will continue to enable our global partners to accelerate and transform biologics development from concept to commercialization.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics